z-logo
open-access-imgOpen Access
Disappearance of Vaccine-Type Invasive Pneumococcal Disease and Emergence of Serotype 19A in a Minority Population with a High Prevalence of Human Immunodeficiency Virus and Low Childhood Immunization Rates
Author(s) -
Azadeh Tasslimi,
Erica J. Sison,
Elizabeth StoryRoller,
David Alland,
Michele Burday,
Susan Morrison,
Sandhya Nalmas,
Stephen W. Smith,
P. Thomas,
Peter Wenger,
Anushua Sinha
Publication year - 2009
Publication title -
clinical and vaccine immunology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.649
H-Index - 77
eISSN - 1556-6811
pISSN - 1556-679X
DOI - 10.1128/cvi.00140-09
Subject(s) - immunization , pneumococcal disease , serotype , pneumococcal vaccine , medicine , virology , population , epidemiology , disease , immunology , streptococcus pneumoniae , biology , environmental health , antibody , microbiology and biotechnology , antibiotics
We analyzed the epidemiology of invasive pneumococcal disease (IPD) following introduction of pneumococcal conjugated vaccine in an urban population with a 2% human immunodeficiency virus (HIV) prevalence and history of low childhood immunization rates. We observed near-elimination of vaccine-type IPD. Substantial disease remains due to non-vaccine-type pneumococci, highlighting the need to increase pneumococcal immunization among HIV-infected adults.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.
Having issues? You can contact us here
Accelerating Research

Address

John Eccles House
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom